Mechanisms of muscle wasting in chronic kidney disease - sprookjes - yvandenbroek - TriplyDB

Mechanisms of muscle wasting in chronic kidney disease

Mechanisms of muscle wasting in chronic kidney disease

http://www.wikidata.org/entity/Q34723810

about

Latest consensus and update on protein-energy wasting in chronic kidney disease Physical inactivity: a risk factor and target for intervention in renal care.A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.Commentary: Renal Function Estimation and Cockcroft-Gault Formulas for Predicting Cardiovascular Mortality in Population-Based, Cardiovascular Risk, Heart Failure and Post-Myocardial Infarction Cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the H The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease.Acupuncture plus Low-Frequency Electrical Stimulation (Acu-LFES) Attenuates Diabetic Myopathy by Enhancing Muscle Regeneration.Aerobic training during hemodialysis improves body composition, muscle function, physical performance, and quality of life in chronic kidney disease patients Relationship between Blood Myostatin Levels and Kidney Function:Shimane CoHRE Study Gender Difference in Bacteria Endotoxin-Induced Inflammatory and Anorexic Responses.Ratio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis.Acid-Base Homeostasis Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis.Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney disease.CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation.Very low protein diets supplemented with keto-analogues in ESRD predialysis patients and its effect on vascular stiffness and AVF Maturation Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies.Acupuncture plus low-frequency electrical stimulation (Acu-LFES) attenuates denervation-induced muscle atrophy.Differential control of muscle mass in type 1 and type 2 diabetes mellitus.Should chronic metabolic acidosis be treated in older people with chronic kidney disease?A Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats.Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α Chronic kidney disease induces autophagy leading to dysfunction of mitochondria in skeletal muscle.Clinical relevance of sarcopenia in chronic kidney disease.Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities.As we grow old: nutritional considerations for older patients on dialysis.Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting.Frailty and Primary Sarcopenia: A Review.Physical function was related to mortality in patients with chronic kidney disease and dialysis.Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1.The Effect of Resistance Exercise on Inflammatory and Myogenic Markers in Patients with Chronic Kidney Disease.MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy.Serum Glucocorticoid-Regulated Kinase 1 Blocks CKD-Induced Muscle Wasting Via Inactivation of FoxO3a and Smad2/3.Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease Glucocorticoid-Regulated Kinase: Linking Azotemia and Muscle Wasting in CKD Studying Muscle Protein Turnover in CKD Low Urinary Creatinine Excretion Is Associated With Self-Reported Frailty in Patients With Advanced Chronic Kidney Disease.Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.

P2860

Q27027875-AD7790B0-C2C9-4A1F-B559-432EC1779CAA Q30238711-261F3297-58BF-4105-B3BC-CADC03F26132 Q30355733-7ADE542D-0C8C-480C-9A5C-5F6ACEAEDDAE Q33785820-5E13E1E1-24A3-409D-BEA7-17F28F48F911 Q35218508-B24AE003-281B-458B-A15F-B2BC1B82DA10 Q35731368-E3B4295F-63F6-44CE-8472-A48FD8C2B033 Q35789916-FD371D5B-00BD-4753-A42D-F07763463471 Q35821417-B8F2FDA0-4CC3-4A6F-87F3-CF168E2B4068 Q36134321-6CF518E9-A260-4FE5-8FDA-8EC257FFE1C0 Q36170858-3D1ABA80-7F79-45D7-B33D-B430D5D3B91A Q36349470-CF5EC2DA-96BC-4C1F-A649-80FFA5EEBFD7 Q36369287-09104C02-F52B-4785-B192-EF47511E9177 Q36497898-EBB3BE0C-BE25-4C8B-BDA9-EE2C622570B6 Q36514936-70AC72A6-B87C-4DF1-8C89-F29E86B7CB0B Q37267970-70778A0C-5954-4856-8FC3-7C9E1BE4FD76 Q37734762-AA196B02-4F8B-4D3F-A514-D4F0CBC440D5 Q38429142-A921CE1C-F11E-4B79-972E-5F1EB4ECE137 Q38440818-1C3E8157-CE99-4FFA-AC4B-9D62279E67B6 Q38474978-6D466855-638B-44E1-93E2-1E5DD6E0BEF4 Q38532367-AC65596F-A138-4D72-97E0-32683234AD4F Q38595572-51B67154-2A80-4340-8149-45253E4A521D Q38611121-9A4FE5A1-79EC-44B8-8694-5AB09EED4711 Q38662525-D2D48F06-C398-4E69-AC62-BA1E5906815F Q38708738-CCBE7004-141D-4BB8-A718-8C20483F71F4 Q38757331-97681505-5091-4285-9CC2-EA305A8B5085 Q38811545-BAA8D1B3-B807-498A-9602-71EAEDD9025B Q38840709-3DFCE6A5-40D1-4CD3-8E7D-5C1B0A87F544 Q39160046-A5240DFC-D87A-4256-B6AC-99788F71F98B Q39223707-FC178BAC-536C-4EB6-8980-8E2984DF6218 Q39248170-88381450-66EC-4753-94B5-CB4FDE7E49FD Q39249156-79BFC41E-5684-43B0-9721-2DF83B6FA062 Q39466056-1016C7CA-7694-4D0A-8E97-F18A08E4ABE1 Q40095248-2BB99827-EB3E-4541-9139-216D2F5E5750 Q40246951-61D3E064-E4ED-4A3A-99EA-A9E5FB0553B2 Q40974306-7CA9912A-4FE2-4E2E-AA82-89442FDCA7C3 Q42144013-BAD7D079-0E57-4A5F-BF2B-EB8B2FF24AFD Q42399760-0FB6F18D-86A4-463D-A624-567ADC7A5285 Q42430337-08CF5727-3AD8-4908-A042-19CBCED97A0B Q47106775-46F7610E-05ED-4E81-9B52-9C3B75F62955 Q47111743-4F233C2B-E78B-49D6-8AD6-7C6D9C34BBD2

P2860

Mechanisms of muscle wasting in chronic kidney disease

http://www.wikidata.org/entity/Q34723810

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mechanisms of muscle wasting in chronic kidney disease

@ast

Mechanisms of muscle wasting in chronic kidney disease

@en

Mechanisms of muscle wasting in chronic kidney disease

@nl

type

label

Mechanisms of muscle wasting in chronic kidney disease

@ast

Mechanisms of muscle wasting in chronic kidney disease

@en

Mechanisms of muscle wasting in chronic kidney disease

@nl

prefLabel

Mechanisms of muscle wasting in chronic kidney disease

@ast

Mechanisms of muscle wasting in chronic kidney disease

@en

Mechanisms of muscle wasting in chronic kidney disease

@nl

P1433

Q34723810-99F125D4-DCD8-4E1A-96B8-D681D1D7AB4C

P1476

Q34723810-CD1B8C9B-E05C-4976-A8DA-7E5C2DF81AB1

P2093

Q34723810-79C232C7-FAB7-45E8-9B21-1C5BE5B89969

Q34723810-A9E004AD-35AA-4EA7-8904-E498E3E9892F

P2860

Q34723810-027B479E-8245-442B-9AC7-85A671BEE8F3

Q34723810-03C01796-0C63-4684-9989-9B2ABB057B4A

Q34723810-10FE21C4-DC1A-478E-8E6D-E1E006B8C684

Q34723810-18371045-B86D-4095-B0BC-26607069EA4E

Q34723810-188AA11A-7D17-40E7-9CC7-A8883317506B

Q34723810-1A65ED01-100A-4335-9C98-86581FB1E240

Q34723810-24A2D521-E05F-42E6-BAC1-7F975E8A1DD8

Q34723810-27A191B2-4DC0-4F07-BBEF-756F6C29D603

Q34723810-2B738E31-F976-492B-9232-C19BA1C9E698

Q34723810-2E7E2BD1-C29E-4D69-BEC3-0C52E320B7AC

P2888

Q34723810-2D97492D-787A-4B93-85F2-29CC9C6DDCA5

P304

Q34723810-50B49176-A798-4DBF-9FD9-CDE4684160B6

P31

Q34723810-82E5D794-8450-4E1E-909F-5BD1A4D71673

P356

Q34723810-D53045C7-6B35-4DB6-B71D-DFE6E028DC75

P407

Q34723810-1EA38F11-C31A-4B70-B638-E9682F84495C

P433

Q34723810-96919200-D25D-44C2-8731-BEA27B12EC0E

P478

Q34723810-B914E270-2C3B-45DF-A897-2AB60EC4E262

P577

Q34723810-0E1EA187-F24E-4286-9C67-76F4A4BE0494

P698

Q34723810-A1B10931-896F-48ED-83CC-8424C38D0F9D

P932

Q34723810-637E9803-B00F-4AD6-9B2C-0544AF48A727

P356

NRNEPH.2014.112

P1433

Nature Reviews Nephrology

P1476

Mechanisms of muscle wasting in chronic kidney disease

@en

P2093

William E Mitch

http://www.w3.org/2001/XMLSchema#string

Xiaonan H Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions

Cellular and molecular mechanisms of muscle atrophy

A gated channel into the proteasome core particle

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases

P2888

nrneph.2014.112

P304

504-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2014.112

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24981816

http://www.w3.org/2001/XMLSchema#string

P932

4269363

http://www.w3.org/2001/XMLSchema#string